Dr. Scott Harris is Principal of Middleburg Consultants, a consulting firm specializing in pharmaceutical development in gastrointestinal diseases. He has led numerous GI studies and programs in the US and rest-of world. Dr. Harris is also Co-Founder and Chief Medical Officer of Lyric Pharmaceuticals and previously served as Chief Medical Officer of Avaxia Biologics, interim Chief Medical Officer of Tranzyme Pharmaceuticals, Chief Medical Officer of Ocera Therapeutics and Chief Medical Officer and Vice President of Clinical Affairs at Napo Pharmaceuticals. He is currently Adjunct Professor of Medicine at Georgetown University School in Washington, DC. Dr. Harris has been a consultant on third-world drug development for the Bill and Melinda Gates Foundation and PATH and a speaker at national and international forums on gastrointestinal drug development. He is a member of the Executive Board of the Center for Diagnostics and Therapeutics of the American Gastroenterological Association.